COMMUNIQUÉS West-GlobeNewswire

Matinas BioPharma Announces Pricing of $8.0 Million Public Offering
19/06/2018
BEDMINSTER, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its [...]
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
19/06/2018
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today detailed its [...]
Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder
19/06/2018
Marigold Study targets rare form of pediatric epilepsy with no approved therapies RADNOR, Pa., June 19, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical [...]
VitalHub Announces Two New Deals for VH LTC Solution
19/06/2018
TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX-V:VHI) is pleased to announce two new sales of its VH LTC solution. The VH LTC solution is designed specifically for Long-Term [...]
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
19/06/2018
Novel Gastroprotective Treatment Demonstrates 3.2 Day Decrease in Hospital Length of Stay Following Surgery Compared to Placebo; LB1148 Triggers Statistically Significant 18-Hour Improvement in Post-Operative Return to [...]
MediWound Expands Its NexoBrid® Phase 3 Children Innovation Debridement Study (CIDS) to the U.S.
19/06/2018
Study fully funded by BARDA YAVNE, Israel, June 19, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn [...]
NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare
19/06/2018
WALTHAM, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that it had achieved the first development milestone under its strategic collaboration with GSK Consumer Healthcare. A [...]
U.S. Department of Defense to Study Pluristem’s PLX-R18 for the Treatment of Mustard Gas Injuries
19/06/2018
Studies to be funded by the U.S. NIH Marks the second project for DOD with PLX-R18 cell therapy product HAIFA, Israel, June 19, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading [...]
Zomedica Provides Product Development Update
19/06/2018
ANN ARBOR, Mich., June 19, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today provided a [...]
U.S. Healthcare Leader Joseph R. Swedish Joins Mesoblast Board
19/06/2018
NEW YORK and MELBOURNE, Australia, June 19, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that Joseph R. Swedish has joined its Board of Directors. Mr. Swedish has more than two [...]
Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP
19/06/2018
RANCHO CUCAMONGA, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has granted approval of its abbreviated new drug [...]
Genetic Technologies Announces Heads of Agreement with Swisstec
19/06/2018
MELBOURNE, Australia, June 19, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“ Company ”, “ GTG ”), a diversified molecular diagnostics company embracing blockchain technologies across [...]
Transactions in relation to share buyback program
19/06/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
HealthLynked Corp. Announces Implementation of Healthcare Algorithms to Provide Personalized Healthcare Recommendations to its Members
19/06/2018
NAPLES, Fla., June 19, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced that it has developed and deployed a number of healthcare algorithms for members that opt in for this service through the [...]
Novo Nordisk A/S - Share repurchase programme
19/06/2018
Bagsværd, Denmark, 19 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Speakeasy Looks to Expand into German Market -- CFN Media
19/06/2018
SEATTLE, June 19, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
C-RAD publishes outcome of Employee Warrant Program 2018/2021
19/06/2018
C-RAD has launched a warrant program for its employees. All warrants that were offered to current employees were subscribed for. The Annual Shareholder Meeting decided in May 2018 to issue 100,000 warrants for the [...]
Constitutive meeting of Biohit Oyj’s Board of Directors
19/06/2018
Biohit Oyj Other information disclosed according to the rules of the Exchange June 19, 2018 at 9:30 am local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the [...]
Shire plc: Rule 2.9 Announcement
19/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 19 June 2018 Shire [...]

Pages